Test: Difference between revisions
From haematologyetc.co.uk
No edit summary |
No edit summary |
||
Line 36: | Line 36: | ||
|colspan="1" style = "font-size:80%;"| | |colspan="1" style = "font-size:80%;"| | ||
|- | |- | ||
|colspan="1" style = "font-size:90%; color:black;" | | |colspan="1" style = "font-size:90%; color:black;" |CD23 | ||
|colspan="1" style = "background:#00b8e6;"| | |colspan="1" style = "background:#00b8e6;"| | ||
|colspan="1" style = "font-size:80%;"|- | |colspan="1" style = "font-size:80%;"|- | ||
|colspan="1" style = "font-size:84%;"| | |colspan="1" style = "font-size:84%;"| | ||
|- | |- | ||
|colspan="1" style = "font-size:90%; color:black;" | | |colspan="1" style = "font-size:90%; color:black;" |CD79b | ||
|colspan="1" style = "background:#006699;"| | |colspan="1" style = "background:#006699;"| | ||
|colspan="1" style = "font-size:80%;"|- | |colspan="1" style = "font-size:80%;"|- | ||
|colspan="1" style = "font-size:84%;"| | |colspan="1" style = "font-size:84%;"| | ||
|- | |- | ||
|colspan="1" style = "font-size:90%; color:black;" | | |colspan="1" style = "font-size:90%; color:black;" |CD200 | ||
|colspan="1" style = "background:#66e0ff;"| | |colspan="1" style = "background:#66e0ff;"| | ||
|colspan="1" style = "font-size:80%;"|- | |colspan="1" style = "font-size:80%;"|- | ||
|colspan="1" style = "font-size:84%;"| | |colspan="1" style = "font-size:84%;"| | ||
|- | |- | ||
|colspan="1" style = "font-size:90%; color:black;" | | |colspan="1" style = "font-size:90%; color:black;" |FMC7 | ||
|colspan="1" style = "background:#006699;"| | |colspan="1" style = "background:#006699;"| | ||
|colspan="1" style = "font-size:80%;"| | |colspan="1" style = "font-size:80%;"| | ||
|colspan="1" style = "font-size:80%;"| | |colspan="1" style = "font-size:80%;"| | ||
|- | |- | ||
!colspan="4" style = "font-size:90%; background:#DAE8F2"|Other relevant markers | !colspan="4" style = "font-size:90%; background:#DAE8F2"|Other relevant markers |
Revision as of 13:49, 12 July 2023
Background to flow cytometric diagnosis
This is an uncommon diagnosis by flow cytometry as DLBCL cells generally circulate and involve bone marrow only at only a late stage in disease (ofetn when a diagnosis has already been made). However, occasionally these cases can present as a new diagnosis by blood or marrow and can be difficult as marker expression is often variable between cases.
Immunophenotype of DLBCL | |||
---|---|---|---|
Major markers useful in CLL diagnosis | |||
Marker | Freq | Level | Comment |
CD19 | - | ||
κ/λ | - | ||
CD5 | - | ||
CD23 | - | ||
CD79b | - | ||
CD200 | - | ||
FMC7 | |||
Other relevant markers | |||
CD10 | - | ||
CD11C | - | ||
CD20 | - | ||
CD25 | - | ||
CD38 | - | ||
CD43 | - | ||
CD103 | - | ||
CD138 | - |
Key to table:
Key to colour code for expression frequency Click for link
Key to expression strength code and use Click for link